Navigation Links
Temporal Approach Lid Speculum - Solid Blade

ProductsTemporal Approach Lid Speculum - Solid Blade
Company Bausch & Lomb Storz
Item Temporal Approach Lid Speculum - Solid Blade
Features 
Description Angled for temporal approach. Solid 14 mm blades. Dull finish.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000
Web site: http://www.storz.com/

Related medicine products :

1. Lehner Temporal Speculum
2. Temporal Approach Lid Speculum
3. Temporal Approach Lid Speculum - Wire Blade
4. Temporal Speculum
5. A Practical Approach to Transesophageal Echocardiography
6. Guyton-Park Speculum
7. Maumenee-Park Speculum
8. Castroviejo Speculum - 15 mm
9. McPherson Speculum
10. Castroviejo Speculum - 16 mm
11. Williams Eye Speculum - 14 mm
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products:
(Date:12/3/2008)...Newswire-USNewswire/ -- The American College of Su...icine (IOM) for its committee report on resident d...y the IOM Committee on Optimizing Graduate Medical...prove Patient Safety. , , ACS agrees with... in the mandated 80-hour work week (averaged over ...
(Date:12/3/2008)...nd Half Times Greater Than Entire U.S. Economy , ...If the federal government stopped the Medicare and...o more payroll taxes and allowing no more accrual ...on to those who have already earned these benefits...for Policy Analysis (NCPA). , , "The numb...
(Date:12/3/2008)...ec. 3 The Belmont(R) Rapid Infuser...port Hospitals to treat wounded,soldiers, civilia... helping to,save the life of an Omaha, NE Police ... during a traffic stop. One of the bullets,hit hi...ng a major artery. , "Injury to this area i...
(Date:12/3/2008)...pond at first not helped by maintenance treatment,...thDay News) -- Maintenance therapy using low-dose ...chronic hepatitis C who haven,t responded to an in..., The study also showed a surprising health decl... of four years. , "This course of treatment had...
Breaking Medicine News(10 mins):Health News:American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours 2Health News:Medicare, Social Security Owe Up to $52 Trillion to Current Retirees and Workers 2Health News:Belmont(R) Rapid Infuser Helps Save Officer's Life 2Health News:Hepatitis C Therapy Useless for Some 2
...The burden of dementia in developing countries is ...s trying to help carers to cope. As the world popu... disease - including dementia. It is hard enough c...tion has been common for many years. Imagine tryin...
...Obesity is a disease and a growing health threat ...upropion can help overweight and obese women lose ...h blood pressure, diabetes, cancer and heart disea...in the long term, and there has seen to be a need,...
...Scientists warn that, too much sleep and snoring c...can researchers from the University of Buffalo, Ne...ours a night, snoring or being drowsy during the d... this means snoring and sleep disorders will now h...
...Men who are regularly exposed to moderate to high ... having a low sperm count, according to a study pu... Environmental Medicine. Professional printers, a...at highest risk. The only factor common to all of ...
Other Medicine News:
(Date:12/1/2008)... Genaera Corporation (N...jects has begun in study MSI-1436C-102 (Study 102)...odusquemine (MSI-1436) in overweight and obese typ... the treatment of type 2 diabetes and obesity whic...ulin and leptin pathways through the highly select...
(Date:12/1/2008)...irstCall/ -- GeoVax Labs, Inc.,(OTC Bulletin Boar...eveloping,human vaccines for diseases caused by H...ectious agents, announced today that the launch of...e in twelve sites across North and South America.,...The National Institutes of,Health (NIH), and the ...
(Date:11/30/2008)...SNewswire/ -- Abnormalities in auditory and langua...tism spectrum disorder by using magnetoencephalogr...t the annual meeting of the Radiological Society o...can record the tiny magnetic fields associated wit..., Ph.D., vice chair of research in the Department ...
(Date:11/27/2008)...of acute lymphoblastic leukemia relapse cases aris...osis , , MEMPHIS, Tenn., Nov. 27 /PRNewswir... Research Hospital have identified distinctive gen...acute lymphoblastic leukemia (ALL) that cause rela...atments for ALL relapse in children and, ultimatel...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 1Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 2Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 3Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 4MedQuist Re launches New Improved Web Site 642 1MedQuist Re launches New Improved Web Site 642 2NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 1NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 2NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 3NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 4Proteon Therapeutics Completes 2412 Million Financing and Hires CFO 404 1Proteon Therapeutics Completes 2412 Million Financing and Hires CFO 404 2
...egistration Program to Begin Third Quarter 2007, H...l/ -- Kosan,Biosciences Incorporated presented dat...f its lead Hsp90 inhibitor, tanespimycin,(KOS-953)...ing a,high degree of antitumor activity and tolera...reviously progressed following treatment,with mult...
...BUSINESS WIRE)--Jun 4, 2007 - Molecular Insight,Ph... that the,company will present the results of seve... of the Society of Nuclear Medicine (SNM) in,Washi...ra(TM),(Ultratrace (131)I-MIBG), the company,s cli...or the treatment of malignant,neuroendocrine tumor...
Other Medicine Technology:Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 2Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 3Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 4Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 5Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 6Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 4